Genxone Spolka Akcyjna Logo

Genxone Spolka Akcyjna

A biotech firm offering nanopore DNA/RNA sequencing services and medical diagnostics.

GX1 | WAR

Overview

Corporate Details

ISIN(s):
PLGENXN00013
LEI:
25940043REFNZY18T558
Country:
Poland
Address:
SUCHY LAS ZŁOTNIKI, KOBALTOWA 6, 62-002 SUCHY LAS
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Genxone S.A. is a biotechnology company specializing in Next-Generation Sequencing (NGS) and medical diagnostics. The company provides nucleic acid (DNA and RNA) sequencing services based on innovative nanopore technology from Oxford Nanopore Technologies. As a pioneer in the field, it was the first laboratory in Poland and among the first globally to implement this technology for commercial use in science, business, and medicine. In addition to its sequencing services, Genxone develops and commercializes its own diagnostic products, including the NANOBIOME gut microbiome test.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-03-08 14:25
Regulatory News Service
Podpisanie umowy warunkowej o istotnym znaczeniu - Content (PL)
Polish 1.2 KB
2024-03-06 16:41
Regulatory News Service
Informacja o wyborze najkorzystniejszej oferty - Content (PL)
Polish 1.8 KB
2023-11-16 15:32
Related Party Transaction
Podpisanie umowy warunkowej o istotnym znaczeniu - Content (PL)
Polish 1.1 KB
2023-11-14 14:32
Legal Proceedings Report
Informacja o wyborze najkorzystniejszej oferty - Content (PL)
Polish 1.7 KB
2023-10-23 16:34
Regulatory News Service
Aktualizacja informacji na temat umowy warunkowej o istotnym znaczeniu - Conten…
Polish 948 bytes
2023-07-20 15:09
M&A Activity
Zawarcie istotnej umowy - Content (PL)
Polish 1.0 KB
2023-06-19 15:31
Declaration of Voting Results & Voting Rights Announcements
Lista akcjonariuszy posiadających co najmniej 5% głosów na Zwyczajnym Walnym Zg…
Polish 470 bytes
2023-05-22 15:37
Business and Financial Review
Sprawozdanie RN genXone za 2022 rok
Polish 991.6 KB
2023-05-22 15:37
Pre-Annual General Meeting Information
Projekty uchwał WZA genXone SA
Polish 284.6 KB
2023-05-22 15:37
Pre-Annual General Meeting Information
Ogłoszenie o zwołaniu Zwyczajnego Walnego Zgromadzenia Spółki genXone SA
Polish 291.5 KB
2023-05-22 15:37
Pre-Annual General Meeting Information
Ogłoszenie o zwołaniu Zwyczajnego Walnego Zgromadzenia Spółki genXone S.A. na d…
Polish 6.6 KB
2023-05-09 15:57
Related Party Transaction
Podpisanie umowy warunkowej o istotnym znaczeniu - Content (PL)
Polish 857 bytes
2023-05-05 16:54
Related Party Transaction
Informacja o wyborze najkorzystniejszej oferty - Content (PL)
Polish 1.5 KB
2023-04-26 17:03
Regulatory News Service
Aktualizacja informacji na temat prac badawczych w ramach projektu NANOBIOME - …
Polish 1.7 KB
2023-03-21 08:05
Director's Dealing
Zawiadomienia_o_transakcjach_osoby_zobowiazanej_Jakub_Swadzba_20230320.pdf
Polish 9.7 KB

Automate Your Workflow. Get a real-time feed of all Genxone Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Genxone Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Read Gene Spolka Akcyjna Logo
Develops DNA tests to identify genetic cancer risk for early detection and prevention.
Poland RDG
RELIEF Therapeutics Holding AG Logo
Developing and commercializing novel therapies for rare and ultra-rare diseases.
Switzerland RLF
RYVU Therapeutics S.A. Logo
Clinical-stage drug discovery company developing novel small molecule therapies for oncology.
Poland RVU
SAREUM HOLDINGS PLC Logo
Clinical-stage developer of kinase inhibitors for autoimmune disease & cancer.
United Kingdom SAR
SCANCELL HOLDINGS PLC Logo
Developing therapeutic vaccines and antibodies for cancer and infectious diseases.
United Kingdom SCLP
SCIENCE GROUP PLC Logo
International science & tech consultancy providing advisory, R&D, and product development.
United Kingdom SAG
Selvita S.A. Logo
Preclinical CRO offering integrated drug discovery and development services for life sciences.
Poland SLV
Simris Group AB Logo
Develops novel cyanobacteria-based payloads for Antibody-Drug Conjugates to treat cancer.
Sweden SIMRIS
SKINBIOTHERAPEUTICS PLC Logo
A life science company developing microbiome-based skin health products and supplements.
United Kingdom SBTX
Terranet B Logo
Develops ultra-fast ADAS anti-collision technology for automakers to protect vulnerable road users.
Sweden TERRNT

Talk to a Data Expert

Have a question? We'll get back to you promptly.